Laurion Capital Management LP Q2 2016 Filing
Filed August 12, 2016
Portfolio Value
$6.4B
Holdings
603
Report Date
Q2 2016
Filing Type
13F-HR
All Holdings (603 positions)
| Stock | Value |
|---|---|
—CELLDEX THERAPEUTICS INC NEW | $65K |
—NEOVASC INC | $56K |
—CTI BIOPHARMA CORP | $55K |
PreviousPage 7 of 7